This Q3 can be have better result if Spore side revenue is maintain but explain from management is due to timing of project completion/recognition issue.
And China side have impressive progress and it have profit guarantee for two years, so it should be quite consistent.
One thing need to take note is the inorganic grow for company might not stop as it might still have fund raising/borrowing to support the growth plan.
Happy trading!